An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation
- DOI
- 10.2196/73156
- Published
- 2026-07-30
- Container
- JMIR Cancer
- Publisher
- JMIR Publications Inc.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2196/73156,
title = {An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation},
author = {Ellen G Engelhardt and Mariska Q N Hackert and Anne Vogelaar and Afke F de Jong and Cristina Guerrero Paez and Annette W G van der Velden and Christa Putker and Mariette J Agterof and Ewoudt M W van de Garde and Cornelia F van Uden-Kraan},
year = {2026},
journal = {JMIR Cancer},
doi = {10.2196/73156},
url = {https://doi.org/10.2196/73156}
}RIS
TY - JOUR TI - An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation AU - Ellen G Engelhardt AU - Mariska Q N Hackert AU - Anne Vogelaar AU - Afke F de Jong AU - Cristina Guerrero Paez AU - Annette W G van der Velden AU - Christa Putker AU - Mariette J Agterof AU - Ewoudt M W van de Garde AU - Cornelia F van Uden-Kraan PY - 2026 JO - JMIR Cancer DO - 10.2196/73156 UR - https://doi.org/10.2196/73156 ER -
APA
Engelhardt, E. G., Hackert, M. Q. N., Vogelaar, A., Jong, A. F. D., Paez, C. G., Velden, A. W. G. V. D., Putker, C., Agterof, M. J., Garde, E. M. W. V. D., & Uden-Kraan, C. F. V. (2026). An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation. JMIR Cancer. https://doi.org/10.2196/73156
Source records
- crossref · retrieved 2026-09-26T15:38:15.888Z